Comparing supplemental indications for cancer drugs approved in the US and EU
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2024.114330 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Jelle Stoelinga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Wo…. Hauptthemen laut MEDLINE: Drug Approval, Antineoplastic Agents, Neoplasms, European Union. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Arnold Ventures LLC, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; School of…
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
- Department of Statistics, the Ohio State University, Columbus, OH, USA.
- Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Division o…
Förderung
- Arnold Ventures LLC
- National Heart, Lung, and Blood Institute
Zitieren
APA
Stoelinga, J., Bloem, L. T., Russo, M., Kesselheim, A. S., & Feldman, W. B. (2024). Comparing supplemental indications for cancer drugs approved in the US and EU. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114330
Vancouver
Stoelinga J, Bloem LT, Russo M, Kesselheim AS, Feldman WB. Comparing supplemental indications for cancer drugs approved in the US and EU. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114330
BibTeX
@article{Stoelinga2024,
author = {Stoelinga, Jelle and Bloem, Lourens T and Russo, Massimiliano and Kesselheim, Aaron S and Feldman, William B},
title = {Comparing supplemental indications for cancer drugs approved in the US and EU},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2024.114330}
}
EUVIMED